Epirubicin and cough Patient Reports February 12, 2012

Epirubicin Side Effects Report #5492822-3
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 10, 2007. Female patient was diagnosed with lung neoplasm and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, brain natriuretic peptide increased, cardiac failure acute, cough, dilatation ventricular, ejection fraction decreased, gallop rhythm present, hepatic function abnormal, hyperhidrosis. Epirubicin dosage: 450 MG/M2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE. Patient recovered.

Epirubicin Side Effects Report #4837471-2
Epirubicin side effect was reported by a Physician from UNITED KINGDOM on Nov 10, 2005. Female patient, 68 years of age, weighting 200.6 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cough, fatigue, leukopenia, lower respiratory tract infection, neutropenia, pharyngolaryngeal pain. Epirubicin dosage: 100 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4854387-6
Epirubicin side effect was reported by a Physician from UNITED KINGDOM on Nov 30, 2005. Female patient, 68 years of age, weighting 200.6 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cough, fatigue, leukopenia, lower respiratory tract infection, neutropenia, pharyngolaryngeal pain. Epirubicin dosage: 100 MG INTRAVENOUS. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4730151-3
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on July 15, 2005. Female patient, 67 years of age, weighting 145.5 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: chest pain , cough, dyspnoea, myocardial infarction. Epirubicin dosage: 85 MG, INTRAVENOUS. During the same period patient was treated with SIMVASTATIN, ATENOLOL, ASPIRIN. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #4741837-9
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on July 26, 2005. Female patient, 67 years of age, weighting 145.5 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cough, dyspnoea, myocardial infarction, post procedural complication. Epirubicin dosage: 85 MG, INTRAVENOUS. During the same period patient was treated with SIMVASTATIN, ATENOLOL, ASPIRIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5313004-1
Epirubicin side effect was reported by a Health Professional from FRANCE on Apr 19, 2007. Female patient, 41 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cough, dyspnoea, obliterative bronchiolitis. Epirubicin dosage: unknown. During the same period patient was treated with ENDOXAN, PRIMPERAN, ZOPHREN, FLUOROURACIL, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #6097787-1
Epirubicin side effect was reported by a Health Professional from SPAIN on Feb 16, 2009. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cough, pancytopenia, pyrexia. Epirubicin dosage: 114 MG (50 MG), CYCLIC. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4629871-0
Epirubicin side effect was reported by a Physician from on Mar 24, 2005. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with ill-defined disorder and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, cough, cryptogenic organizing pneumonia, myalgia, pulmonary hypertension , pulmonary veno-occlusive disease, viral infection . Epirubicin dosage: 60 MG (CYCLIC INTERVAL: EVERY MONTH), INTRAVENOUS. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4645529-6
Epirubicin side effect was reported by a Physician from on Apr 15, 2005. Male patient, 48 years of age, was treated with Epirubicin. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, cough, cryptogenic organizing pneumonia, myalgia, pulmonary hypertension , pulmonary veno-occlusive disease, viral infection . Epirubicin dosage: 60 MG (2 CYCLE INTERVAL: DAILY), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CYCLOPHOSPHAMIDE, PREDNISOLONE PHOSPHATE. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #4738455-5
Epirubicin side effect was reported by a Physician from FRANCE on July 21, 2005. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with ill-defined disorder and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, cough, cryptogenic organizing pneumonia, myalgia, pulmonary hypertension , pulmonary veno-occlusive disease. Epirubicin dosage: 60 MG (CYCLIC INTERVAL: EVERY MONTH), INTRAVENOUS. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.